Global PoC Platform And Technology Overview
PoC Platform and Technology Market accounted for US$ 45.0 Billion in 2024 and is estimated to be US$ 101.1 Billion by 2034 and is anticipated to register a CAGR of 8.40%.
Point of care testing in molecular diagnostics has a wide application base that includes near patient testing in infectious disease management, oncology, hematology, prenatal testing, endocrinology and some other minor applications.
North America dominates the global PoC platform and technology market and is expected to maintain its dominancy over the forecast period owing to growing prevalence of lifestyle diseases, rising government initiatives and increasing number of product approvals in this region.
The markets in Asia Pacific are expected to show significant growth rates in global PoC platform and technology market. This can be attributed to increasing, technological advancements and new product launches, in the region.
Moreover, high prevalence of infectious diseases in developing countries coupled with the increasing incidence of target diseases are another factors expected to propel growth of the target market in the near future.
However, pricing pressure owing to reimbursement cuts and budget constraints is a major factor expected to hamper growth of the global PoC platform and technology market over the forecast period.
For More Report Details, Download Free Sample PDF
Global PoC Platform And Technology Segmentations & Regional Insights
The global PoC platform and technology market has been segmented on the basis of product, platform, mode, end user, and region.
The product segment includes glucose monitoring products, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy & fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, fecal occult testing products, and other PoC products. On the basis of platform the global PoC platform and technology market has been segmented lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. On the basis of mode the global PoC platform and technology market has been segmented prescription-based testing, otc-based testing. The end-user segment includes professional diagnostic centers, research laboratories, home care, and other end users.
On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account major market share as compared to that of other regions
Global PoC Platform And Technology Competitive Landscape & Key Players
Key players operating in the global PoC platform and technology market includes point-of-care diagnostics market was dominated by Roche, Abbott, Siemens, Instrumentation Laboratory, Nova, PTS Diagnostics, Sekisui Diagnostics, Quidel, EKF Diagnostics, Chembio Diagnostics, Trinity Biotech, and AccuBioTech.
FAQs
The global PoC platform and technology market has been segmented on the basis of product, platform, mode, end user, and region.
high prevalence of infectious diseases in developing countries coupled with the increasing incidence of target diseases are another factors expected to propel growth of the target market in the near future.
North America dominates the global PoC platform and technology market and is expected to maintain its dominancy over the forecast period owing to growing prevalence of lifestyle diseases, rising government initiatives and increasing number of product approvals in this region
Pricing pressure owing to reimbursement cuts and budget constraints is a major factor expected to hamper growth of the global PoC platform and technology market over the forecast period.
Key players operating in the global PoC platform and technology market includes point-of-care diagnostics market was dominated by Roche, Abbott, Siemens, Instrumentation Laboratory, Nova, PTS Diagnostics, Sekisui Diagnostics, Quidel, EKF Diagnostics, Chembio Diagnostics, Trinity Biotech, and AccuBioTech.